You're reading the free version. Trader adds the live tape and alerts.
Start tracking
NRIX Sale Disclosure
Ring Christine · SEC Form 4 · Filed Jun 25, 2026
Sale
Calculated transaction value
$580.51K
Ring Christine Chief Legal Officer
NRIX
Nurix Therapeutics
NRIX
Transaction date
Jun 25, 2026
Public filing date
Jun 25, 2026
Filing lag
Filed same day
NRIX daily price context
Close on/before transaction
$22.46
Jun 25, 2026
First close after public filing
$22.9
Jun 26, 2026
30-day return after filing
+2.31%
Through Jul 27, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 28,935 shares @ $20.06
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001817199-26-000022
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$813.35K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Nurix Therapeutics, Inc. NRIX | Exercise | Jun 25, 2026 | $96.8K |
| Nurix Therapeutics, Inc. NRIX | Exercise | Jun 25, 2026 | $136.05K |
| Nurix Therapeutics, Inc. NRIX Current | Sale | Jun 25, 2026 | $580.51K |
| Nurix Therapeutics, Inc. NRIX | Exercise | Jun 25, 2026 | $0 |
| Nurix Therapeutics, Inc. NRIX | Exercise | Jun 25, 2026 | $0 |